Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 2007 Top 20 Pharmaceutical Companies Report | Contract Pharma

What are you searching for?

Sign in
Features

2007 Top 20 Pharmaceutical Companies Report

Pfizer's at the top of the roost, but one hare-brained mega-acquisition by GlaxoSmithKline or Sanofi could topple them.

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

2007 Top 20 Pharmaceutical Companies Report



Pfizer’s at the top of the roost, but one hare-brained mega-acquisition by GlaxoSmithKline or Sanofi could topple them. Companies #2-5 are all foreign, but seven of the next eight are based in the U.S.; I have no idea what that’s supposed to signify. Demonstrating how tough it is to stay at the top, only four companies in the top 10 reached double-digit sales growth.

The largest increase in revenues was Novartis’ $3.3 billion, but almost 30% of that came from its purchase of Chiron. GSK had the greatest “organic”  growth, adding $3.0 billion in revenues. Bristol-Myers Squibb and Abbott Laboratories suffered the most last year, shedding $1.4 billion and $1.3 billion in revenues, respectively.

Several companies near the bottom of our list moved up thanks to strategic acquisitions; Bayer’s purchase of Schering AG led to the biggest jump by any company on the list, from #20 to #16. Let’s hope no one else gets any bright ideas . . .

—Gil Y. Roth, Editor

 

Top 20 Pharmaceutical Companies
01 Pfizer $45,083
02 GlaxoSmithKline $37,003
03 Sanofi-Aventis $35,643
04 AstraZeneca $25,741
05 Novartis $23,532
06 Merck $23,425
07 Johnson & Johnson $23,267
08 Roche $19,300
09 Wyeth $15,683
10 Eli Lilly & Co. $14,816
11 Bristol-Myers Squibb $13,861
12 Abbott Laboratories $12,395
13 Schering-Plough $10,461
14 Boehringer-Ingelheim $10,440
15 Takeda $9,793
16 Bayer AG $8,518
17 Astellas $7,862
18 Daiichi-Sankyo $7,166
19 Eisai $5,589
20 Merck KgA $4,674

Based on 2006 pharma revenues.
Note: In all Top Company profiles, dollar amounts are in millions.
For the online edition, pipeline and patent expiry info is only available for companies #1-5.

 

Contributors


Editor: Gil Y. Roth
Associate Editor: Kristin Brooks
Contributing Editor: Derek B. Lowe
All profiles written by Gil Roth, except Abbott Laboratories and Boehringer-Ingelheim, by Kristin Brooks.

All pipeline information compiled by Kristin Brooks

Photo courtesy of Bristol-Myers Squibb

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters